000 | 01956 a2200517 4500 | ||
---|---|---|---|
005 | 20250515053033.0 | ||
264 | 0 | _c20070320 | |
008 | 200703s 0 0 eng d | ||
022 | _a0022-3484 | ||
024 | 7 |
_a10.1111/j.1600-0765.2006.00911.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNareika, A | |
245 | 0 | 0 |
_aHigh glucose-boosted inflammatory responses to lipopolysaccharide are suppressed by statin. _h[electronic resource] |
260 |
_bJournal of periodontal research _cFeb 2007 |
||
300 |
_a31-8 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 |
_aChemokines _xantagonists & inhibitors |
650 | 0 | 4 |
_aCytokines _xantagonists & inhibitors |
650 | 0 | 4 |
_aFenofibrate _xpharmacology |
650 | 0 | 4 |
_aGlucose _xadministration & dosage |
650 | 0 | 4 |
_aHistiocytes _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
650 | 0 | 4 |
_aHypolipidemic Agents _xpharmacology |
650 | 0 | 4 |
_aInflammation Mediators _xmetabolism |
650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xmetabolism |
650 | 0 | 4 |
_aPeroxisome Proliferator-Activated Receptors _xagonists |
650 | 0 | 4 | _aPioglitazone |
650 | 0 | 4 |
_aSimvastatin _xpharmacology |
650 | 0 | 4 |
_aThiazolidinediones _xpharmacology |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aU937 Cells |
700 | 1 | _aMaldonado, A | |
700 | 1 | _aHe, L | |
700 | 1 | _aGame, B A | |
700 | 1 | _aSlate, E H | |
700 | 1 | _aSanders, J J | |
700 | 1 | _aLondon, S D | |
700 | 1 | _aLopes-Virella, M F | |
700 | 1 | _aHuang, Y | |
773 | 0 |
_tJournal of periodontal research _gvol. 42 _gno. 1 _gp. 31-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1600-0765.2006.00911.x _zAvailable from publisher's website |
999 |
_c16780246 _d16780246 |